Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects With Chronic Hepatitis B Virus Infection
Conditions
Interventions
TAF
Placebo
Locations
62
United States
Children's Hospital of Los Angeles
Los Angeles, California, United States
Rady Childrens Hospital
San Diego, California, United States
University of California, San Francisco (UCSF)
San Francisco, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
University of Miami/Schiff Center for Liver Diseases
Miami, Florida, United States
AdventHealth Medical Group
Orlando, Florida, United States
Start Date
November 1, 2016
Primary Completion Date
September 1, 2026
Completion Date
October 1, 2029
Last Updated
April 3, 2026
NCT07417553
NCT06671093
NCT05853718
NCT06885710
NCT06906016
NCT06263959
Lead Sponsor
Gilead Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions